Drreddys Laboratories | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
ANI Pharmaceuticals USD 149.8M 4.94M 2025-03
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bayer EUR 4.02B 2.18B 2025-03
Canopy Growth CAD 16.31M 69.8M 2024-12
Cipla INR 8B 1.22B 2025-03
Corcept Therapeutics USD 89.82M 37.85M 2025-03
Drreddys Laboratories INR 1.1B 743M 2024-12
GlaxoSmithKline GBP 4.46B 594M 2025-03
Hikma Pharmaceutical USD 0 1000K 2024-06
Lonza CHF 1.11B 286M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pacira USD 283.61M 6.84M 2025-03
Prestige Brands USD 97.88M 47.01M 2025-03
Richter Gedeon HUF 135.63B 61.59B 2024-12
Sun Pharmaceuticals INR 113.32B 33.19B 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Teva Pharmaceutical Industries USD 1.7B 1.6B 2025-03



Drreddys Laboratories Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.